A lawyer who says she gave a drug company the idea to use thalidomide as a cancer treatment has won the right to pursue a claim that the company reneged on the promise of a reward and owes her $300 million.
U.S. District Judge Faith Hochberg in Newark, N.J., ruled on Wednesday that Beth Jacobson, who allegedly gave Celgene Corp. the thalidomide idea in 1997, can engage in discovery to defeat its motion for dismissal of the suit as time-barred.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
For questions call 1-877-256-2472 or contact us at [email protected]